Tanaka Ken-Ichiro
Laboratory of Bio-Analytical Chemistry, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo, Tokyo, Japan.
Front Public Health. 2025 Sep 3;13:1652263. doi: 10.3389/fpubh.2025.1652263. eCollection 2025.
Although Sustainable Development Goal 3.9 states the global goal of reducing air pollution-related death and disease, innovative ways to reduce air pollution-related deaths and diseases have not yet been established. To address this issue, we have established animal models using urban air dust containing the major air pollutants, suspended particulate matter (PM) and fine particulate matter (PM), and are promoting research to discover protective factors in the respiratory tract where air pollutants first reach the human body. Therefore, in this Perspective manuscript, we provide an overview of our research on the preventive effects of the endogenous protein metallothionein on air pollutant-dependent lung injury and prospects for the clinical application of metallothionein inducers. We hope that this manuscript will help to solve health hazards caused by air pollution.
虽然可持续发展目标3.9提出了减少与空气污染相关的死亡和疾病这一全球目标,但尚未确立减少与空气污染相关的死亡和疾病的创新方法。为解决这一问题,我们利用含有主要空气污染物悬浮颗粒物(PM)和细颗粒物(PM)的城市空气尘埃建立了动物模型,并正在推进研究,以发现空气污染物首先进入人体的呼吸道中的保护因子。因此,在这篇观点手稿中,我们概述了我们关于内源性蛋白质金属硫蛋白对空气污染物依赖性肺损伤的预防作用的研究,以及金属硫蛋白诱导剂临床应用的前景。我们希望这篇手稿将有助于解决空气污染造成的健康危害。